Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Execs On The Move: New Research Chief At Biovica; Convergent Dental And XACT Robotics Find Sales VPs
Swedish cancer diagnostics firm Biovica International announces a new R&D director; Convergent Dental, a dental equipment company, and XACT Robotics, a robotics system developer, pick sales veeps; and more.
Italian medical research services firm Newronika, developer of protein motion drug discovery Relay Therapeutics, and orphan lung disease company Savara have selected expert physician-scientist CMOs to lead their investigational programs; and more.
Hahn Fields Queries On Electrical Stim Devices, Molybdenum Supplies For Imaging At FDA Confirmation Hearing
MD Anderson Cancer Center chief medical officer Stephen Hahn fielded a number of questions senators asked at his 20 November confirmation hearing to lead the US FDA. Chief among them were inquiries about his government experience level, whether he would expedite a ban on electrical stimulation devices used against the intellectually disabled, and how he would address a shortage of molybdenum-99 used in advanced imaging scans.
Execs On The Move: J&J And C-RAD Land Talent From Bayer And GE Healthcare; Abbott Eyes A Leadership Change In 2020
J&J chooses a former Bayer exec as chief information officer; C-RAD brings aboard as COO a GE Healthcare software director; Abbott Laboratories announces its longtime CEO will step down in 2020; and more.
Device Week, 14 November 2019 – Medtech Leaders Look To The Future At XMed 2019; Abbott Names New CEO
In this week's podcast, Medtech Insight managing editor Marion Webb summarizes her recent interviews with Ted Tanner, CTO of IBM Watson Health, and Catherine Mohr, president of the Intuitive Foundation, during the Exponential Medicine conference in San Diego. And deputy editor Reed Miller discusses the appointment of Robert Ford as the new CEO of Abbott Laboratories, the latest in a recent series of high-profile CEO appointments in medtech.
Abbott's CEO Miles White will step down at the end of March 2020 after 21 years on the job. Robert Ford, Abbott's president and COO, will succeed White as Abbott's CEO. See what William Osborn, chair of Abbott's board of directors' nominations and governance committee, said about it here.
Abbott’s current COO Robert Ford will become the company’s new CEO on 31 March, 2020. Miles White is stepping down after 21 years leading the diversified health-care products company.
Energy surgical tools developer OmniGuide Holdings welcomes a new VP of global marketing to manage worldwide marketing activities and a managing director for its OmniGuide Surgical Strategic Business Unit to guide technology innovation strategy.
Multinational medtech firm Smith & Nephew hired a seasoned medtech exec as CEO; Metabalon, a health tech metabolomics-focused company, and Varian Medical, a radiation oncology treatment developer, have hired top VPs; and more.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.